Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Cytoreductive Surgery for Colorectal Peritoneal Metastases

In a single-center series of 87 patients undergoing cytoreductive surgery for colorectal peritoneal metastases, postoperative ctDNA was detectable in 30 of 83 (36%) and was associated with shorter recurrence-free survival (HR 3.5), peritoneal recurrence-free survival (HR 3.1), and overall survival (HR 6.7); the abstract does not name the assay, and the paper is about peritoneal, not liver, metastases.

Annals of Surgical Oncology